ION582
- Generic Name
- ION582
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Associated Conditions
- -
- Associated Therapies
- -
HALOS: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Ascending Doses of ION582 in Participants With Angelman Syndrome
- First Posted Date
- 2021-11-19
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- Ionis Pharmaceuticals, Inc.
- Target Recruit Count
- 51
- Registration Number
- NCT05127226
- Locations
- 🇺🇸
Rady Children's Hospital, San Diego, California, United States
🇺🇸Rush University Medical Center, Chicago, Illinois, United States
🇺🇸University of North Carolina at Chapel Hill School of Medicine, Carrboro, North Carolina, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath